Guy Leverger

Author PubWeight™ 61.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood 2012 2.39
2 Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003 2.15
3 SPRED1 disorder and predisposition to leukemia in children. Blood 2009 1.65
4 Thymus and mediastinal node involvement in childhood Langerhans cell histiocytosis: long-term follow-up from the French national cohort. Pediatr Blood Cancer 2013 1.54
5 Romiplostim in children with chronic immune thrombocytopenia (ITP): the French experience. Br J Haematol 2013 1.49
6 Risk factors for Gram-negative bacterial infections in febrile neutropenia. Haematologica 2005 1.44
7 Clinical and biological features at diagnosis in 40 children with chronic myeloid leukemia. Pediatrics 2005 1.39
8 A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 2011 1.36
9 New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica 2011 1.34
10 Rituximab therapy for childhood Evans syndrome. Haematologica 2007 1.33
11 Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study. J Clin Oncol 2008 1.32
12 Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup. Blood 2003 1.24
13 A white blood cell index as the main prognostic factor in t(8;21) acute myeloid leukemia (AML): a survey of 161 cases from the French AML Intergroup. Blood 2002 1.21
14 Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology. J Clin Oncol 2009 1.20
15 Household exposure to pesticides and risk of childhood hematopoietic malignancies: The ESCALE study (SFCE). Environ Health Perspect 2007 1.15
16 Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest 2014 1.13
17 Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J 2008 1.13
18 High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia. J Clin Oncol 2006 1.11
19 Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology. J Clin Oncol 2003 1.09
20 Road traffic and childhood leukemia: the ESCALE study (SFCE). Environ Health Perspect 2010 1.03
21 Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 2005 1.01
22 Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. Clin Infect Dis 2003 1.00
23 Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE). Cancer Causes Control 2008 1.00
24 Breast-feeding, fetal loss and childhood acute leukaemia. Eur J Pediatr 2002 0.96
25 The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest. Haematologica 2013 0.96
26 Septic arthritis caused by Bordetella holmesii in an adolescent with chronic haemolytic anaemia. J Med Microbiol 2011 0.94
27 Contribution of HLA-A/B/C/DRB1/DQB1 common haplotypes to donor search outcome in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011 0.94
28 Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE). Int J Cancer 2007 0.94
29 Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol. Haematologica 2012 0.93
30 MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations. Blood 2012 0.92
31 Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica 2008 0.91
32 Maternal coffee and alcohol consumption during pregnancy, parental smoking and risk of childhood acute leukaemia. Cancer Detect Prev 2005 0.91
33 Pearson syndrome in the neonatal period: two case reports and review of the literature. J Pediatr Hematol Oncol 2009 0.90
34 Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE). Pediatr Blood Cancer 2012 0.90
35 An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children. J Infect Dis 2002 0.90
36 Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE). Cancer Causes Control 2012 0.89
37 Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL Group. J Clin Oncol 2012 0.87
38 High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers. Antimicrob Agents Chemother 2008 0.87
39 Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE study (SFCE). Cancer Causes Control 2011 0.87
40 HLA alleles and haplotypes in French North African immigrants. Hum Immunol 2006 0.87
41 Family history of autoimmune thyroid disease and childhood acute leukemia. Cancer Epidemiol Biomarkers Prev 2003 0.85
42 Interaction between methotrexate and ciprofloxacin. J Pediatr Hematol Oncol 2002 0.85
43 Long-term evaluation of Ifosfamide-related nephrotoxicity in children. J Clin Oncol 2009 0.84
44 Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant. J Clin Oncol 2002 0.84
45 Quantitation of Human herpes virus 6 genome in children with acute lymphoblastic leukemia. J Med Virol 2008 0.82
46 Hematopoietic stem cell transplantation for de novo acute megakaryocytic leukemia in first complete remission: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT). Blood 2004 0.82
47 CD34+ immunoselection of autologous grafts for the treatment of high-risk neuroblastoma. Pediatr Blood Cancer 2011 0.82
48 First isolated extramedullary relapse in children with B-cell precursor acute lymphoblastic leukaemia: results of the Cooprall-97 study. Eur J Cancer 2008 0.81
49 Separate occurrence of extra-adrenal paraganglioma and gastrointestinal stromal tumor in monozygotic twins: probable familial Carney syndrome. Pediatr Dev Pathol 2004 0.81
50 Vaccination and the risk of childhood acute leukaemia: the ESCALE study (SFCE). Int J Epidemiol 2007 0.78
51 [Outcome of children cured of acute lymphoblastic leukemia]. Bull Acad Natl Med 2009 0.78
52 Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms. Cancer Causes Control 2013 0.78
53 Invasive Fungal Infections in Pediatric Acute Myelogenous Leukemia. Pediatr Infect Dis J 2015 0.77
54 Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia. Pediatr Blood Cancer 2006 0.77
55 [Results of a survey on practices in onco-hematology in France in 2001]. Presse Med 2004 0.77
56 C/EBPA methylation is common in T-ALL but not in M0 AML. Blood 2009 0.77
57 SFCE (Société Française de Lutte contre les Cancers et Leucémies de l'Enfant et de l'Adolescent) recommendations for the management of tumor lysis syndrome (TLS) with rasburicase: an observational survey. J Pediatr Hematol Oncol 2008 0.77
58 Imatinib cessation in children and adolescents with chronic myeloid leukemia in chronic phase. Pediatr Blood Cancer 2013 0.76
59 Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study. BMC Cancer 2009 0.75
60 Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia. BMC Cancer 2006 0.75
61 Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2003 0.75
62 [A nursing consultation to improve antiretroviral medication management in children]. Soins Pediatr Pueric 2010 0.75
63 Sporadic Burkitt Lymphoma Presenting as Intestinal Polyposis in a Child. Appl Immunohistochem Mol Morphol 2016 0.75
64 Vinblastine in the treatment of children and adolescents with refractory immune thrombocytopenia. Am J Hematol 2011 0.75
65 [Paediatric specificity of antifungals use]. Therapie 2006 0.75
66 [Towards cure for all children with acute lymphoblastic leukemia?]. Bull Acad Natl Med 2009 0.75
67 Neonatal dumbbell neuroblastoma: a case report, from prenatal diagnosis to postnatal strategy. J Pediatr Hematol Oncol 2015 0.75
68 ACTN1-related Macrothrombocytopenia: A Novel Entity in the Progressing Field of Pediatric Thrombocytopenia. J Pediatr Hematol Oncol 2017 0.75
69 [Reduced intensity allogenic hematopoietic stem cell transplantation in children]. Bull Cancer 2011 0.75
70 Liposomal daunorubicin (Daunoxome) and polyethylated glycol conjugated asparaginase (PEG-ASPA) in children with relapsed and refractory acute lymphoblastic leukemia treated on compassionate basis. J Egypt Natl Canc Inst 2008 0.75
71 [Living after an acute lymphoblastic leukemia]. Soins Pediatr Pueric 2006 0.75
72 Head and neck presentations of B-NHL and B-AL in children/adolescents: experience of the LMB89 study. Pediatr Blood Cancer 2013 0.75
73 Acute leukemia presenting as acute hepatitis without liver failure. J Pediatr Gastroenterol Nutr 2014 0.75
74 [New insights into acute lymphoblastic leukemia]. Bull Acad Natl Med 2009 0.75
75 Clinical and laboratory manifestations of congenital dyserythropoietic anemia type I in a cohort of French children. J Pediatr Hematol Oncol 2005 0.75
76 Molecular response in two children with relapsed acute myeloid leukemia treated with a combination of gemtuzumab ozogamicin and cytarabine. Haematologica 2006 0.75
77 [How to discuss death with a dying child: can a story help?]. Bull Acad Natl Med 2008 0.75